profit outlook

مستقر6 خبر5 مصادرآخر تحديث: 20‏/7‏/2026

أحدث الأخبار

Business·20‏/7‏/2026ملخص الذكاء الاصطناعي

UnitedHealth Group Beats Earnings Estimates, Raises Profit Outlook Amid AI Integration

UnitedHealth Group exceeded second-quarter earnings estimates and increased its full-year profit outlook, driven by improved management of high medical costs and a significant $1.5 billion investment in AI to streamline operations. The company's stock jumped over 7% on the news, despite ongoing elevated medical costs and membership declines.

CNBC US Markets

4 د قراءة

BMW Shares Tumble After Profit Outlook Cut Amid China Slowdown and Iran War

مُلِح

Business·17‏/6‏/2026ملخص الذكاء الاصطناعي

BMW Shares Tumble After Profit Outlook Cut Amid China Slowdown and Iran War

BMW shares dropped to a 5-year low after the German automaker lowered its 2026 profit forecast due to declining demand in China and disruptions from the Iran war impacting costs and consumer sentiment. Analysts expressed concern over a lack of clarity on company structures and costs.

CNBC World

2 د قراءة

BMW Forecasts Significant Profit Drop Amidst China Slowdown and Middle East Crisis

يتطور

Business·17‏/6‏/2026ملخص الذكاء الاصطناعي

BMW Forecasts Significant Profit Drop Amidst China Slowdown and Middle East Crisis

BMW AG anticipates a substantial decline in pre-tax profit due to weakening demand in China and the impact of the Middle East crisis. The company has lowered its profitability targets and plans to accelerate cost-cutting measures.

Euronews Business

3 د قراءة

Merck Q1 Results Beat Estimates on Keytruda Demand, Raises 2026 Guidance

خبر

30‏/4‏/2026ملخص الذكاء الاصطناعي

Merck Q1 Results Beat Estimates on Keytruda Demand, Raises 2026 Guidance

Merck reported first-quarter 2026 results exceeding Wall Street expectations with $16.29B revenue, driven by strong Keytruda sales of $8.03B (up 12%). The pharma giant narrowed its 2026 revenue guidance to $65.8B-$67B and raised adjusted earnings outlook to $5.04-$5.16 per share. The company posted a net loss of $4.24B due to a $3.62 per share charge from its Cidara Therapeutics acquisition, part of its strategy to offset upcoming generic competition for Keytruda in 2028 and diabetes drugs Januvia/Janumet later this year.

CNBC

2 د قراءة

Reliance Industries Q4FY26 Earnings: Mixed Performance Expected as Brokerages Diverge on Profit Outlook

يتطور

Business·24‏/4‏/2026ملخص الذكاء الاصطناعي

Reliance Industries Q4FY26 Earnings: Mixed Performance Expected as Brokerages Diverge on Profit Outlook

Reliance Industries is expected to report mixed Q4FY26 performance with revenue growth of 8%-13% but profitability pressure. Net profit is projected in the range of Rs 16,200 crore to Rs 23,053 crore, with YES Securities forecasting 2% YoY growth while others expect declines of 4.7%-17%. O2C and upstream segments are likely to drag performance while telecom (Jio) and retail will provide support. EBITDA is expected to remain largely stable YoY. RIL will announce earnings on Friday, April 24.

Economic Times

2 د قراءة

UnitedHealth Posts Strong Q1 Earnings, Raises 2026 Profit Outlook

خبر

21‏/4‏/2026ملخص الذكاء الاصطناعي

UnitedHealth Posts Strong Q1 Earnings, Raises 2026 Profit Outlook

UnitedHealth Group reported Q1 earnings of $7.23 per share, beating estimates of $6.57, with revenue of $111.72B. The company raised its 2026 profit outlook to over $18.25 per share, citing improved medical cost management and operational streamlining.

CNBC

2 د قراءة